バイオ医薬品産業におけるオートメーションの世界市場レポート 2025年

バイオ医薬品産業におけるオートメーション市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.4％で29億2,000万米ドルに成長します。予測期間の成長は、データの完全性と文書化の強化、個別化医療の台頭、モジュール式でフレキシブルなバイオプロセス施設の台頭、自動化プラットフォームの進化、バイオシミラー需要の高まり、スマートセンサーとモノのインターネット（iot）の採用に起因します。予測期間における主な動向には、ロボット工学と自動化技術の進歩、シングルユース技術の進歩、バイオプロセスにおける人工知能の統合、プロセス分析技術（PAT）の進歩、バイオ医薬品企業とテクノロジー企業の協働、バイオ医薬品自動化における持続可能性の重視などがあります。

医薬品製造におけるロボット導入の増加は、バイオ医薬品産業における自動化市場の成長を促進すると予想されます。ここでいうロボットとは、医薬品の製造やパッケージングにおいて様々な作業を行う先進の自動化システムや機械を指します。二次包装、イントラロジスティクス、ラボラトリーオートメーション、ピック＆プレイス、薬局プロセスオートメーション、個別化医療など、医薬品製造における複数のアプリケーションで活用されています。これにより、生産性の向上、精度の向上、汚染リスクの低減、作業者の安全性の向上が実現します。例えば2024年9月、ドイツを拠点とする専門非営利団体である国際ロボット連盟は、欧州の製造業における産業用ロボットの導入台数が9％増加し、過去最高の9万2,393台に達したと報告しました。このうち80％は欧州連合（EU）域内に設置され、総設置台数は7万3,534台（前年比2％増）となった。従って、医薬品製造におけるロボット導入の増加は、バイオ医薬品産業市場における自動化の拡大を促進すると思われます。

バイオ医薬品産業市場における自動化の成長は、医薬品開発のペースアップによってさらに促進されると予想されます。医薬品開発のプロセスには、新しい医薬品の発見と市場への導入が含まれます。医薬品開発が激化するにつれ、バイオ医薬品業界ではプロセスの自動化が不可欠となります。自動化システムは、プロセスの合理化、研究の迅速化、精度の確保、全体的な効率の向上において重要な役割を果たしています。例えば、2022年、医薬品評価研究センター（CDER）は、新薬に分類される37の新薬に承認を与え、その54％が同年中に承認を受けた。したがって、医薬品開発活動の急増は、バイオ医薬品産業市場における自動化の成長の触媒として機能します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界バイオ医薬品産業におけるオートメーションPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のバイオ医薬品産業におけるオートメーション市場：成長率分析
• 世界のバイオ医薬品産業におけるオートメーション市場の実績：規模と成長, 2019-2024
• 世界のバイオ医薬品産業におけるオートメーション市場の予測：規模と成長, 2024-2029, 2034F
• 世界バイオ医薬品産業におけるオートメーション総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオ医薬品産業におけるオートメーション市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動化技術
• デジタル化技術
• 世界のバイオ医薬品産業におけるオートメーション市場：コンポーネント別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動化ハードウェア
• 自動化ソフトウェア
• サービスプロジェクトフェーズ
• サービス運用フェーズ
• 世界のバイオ医薬品産業におけるオートメーション市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床段階
• 創薬フェーズ
• 生産段階
• 世界のバイオ医薬品産業におけるオートメーション市場、自動化技術のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プロセス自動化
• ラボオートメーション
• ロボット工学と人工知能
• 制御システム
• プログラマブルロジックコントローラ（PLC）
• 世界のバイオ医薬品産業におけるオートメーション市場デジタル化技術のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• データ分析と視覚化
• 電子ラボノート（ELN）
• クラウドコンピューティング
• 製薬業界におけるモノのインターネット（IoT）
• デジタルツインテクノロジー

第7章 地域別・国別分析

• 世界のバイオ医薬品産業におけるオートメーション市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバイオ医薬品産業におけるオートメーション市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオ医薬品産業におけるオートメーション市場：競合情勢
• バイオ医薬品産業におけるオートメーション市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • ABB Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Emerson Electric Co.
• Becton Dickinson and Company（BD）
• Corning Incorporated
• Rockwell Automation Inc.
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Sartorius AG
• bioMerieux SA
• Mettler-Toledo International Inc.
• Beckman Coulter Inc.
• Waters Corporation
• Pall Corporation
• Bruker Corporation
• Qiagen N.V.
• Eppendorf AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バイオ医薬品産業におけるオートメーション市場2029：新たな機会を提供する国
• バイオ医薬品産業におけるオートメーション市場2029：新たな機会を提供するセグメント
• バイオ医薬品産業におけるオートメーション市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Automation within the biopharma industry involves the incorporation of advanced technologies and robotics across different stages of the biopharmaceutical manufacturing process. This entails utilizing automated systems and equipment to execute tasks that were conventionally handled by humans, with the aim of enhancing efficiency, precision, and overall productivity in the production of biopharmaceutical products.

The principal technologies driving automation in the biopharma industry encompass automation technology and digitization technology. Automation technology encompasses the utilization of diverse technologies, such as robotics, artificial intelligence (AI), and software systems, to automate and streamline processes and tasks that were traditionally carried out by humans. This includes various components such as automation hardware, automation software, service project phases, and service operation phases, with applications spanning clinical phases, drug discovery phases, and production phases.

The automation in biopharma industry research report is one of a series of new reports from The Business Research Company that provides automation in biopharma industry market statistics, including the automation in biopharma industry's global market size, regional shares, competitors with a automation in biopharma industry market share, detailed automation in biopharma industry market segments, market trends and opportunities, and any further data you may need to thrive in the automation in biopharma industry. This automation in the biopharma industry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The automation in biopharma industry market size has grown strongly in recent years. It will grow from $2.08 billion in 2024 to $2.2 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increased complexity in biopharmaceutical processes, need for improved process efficiency, growth in biologics development and manufacturing, demand for quality assurance and control, pressure to reduce time-to-market

The automation in biopharma industry market size is expected to see strong growth in the next few years. It will grow to $2.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to enhanced data integrity and documentation, rise of personalized medicine, rise of modular and flexible bioprocessing facilities, evolution of automation platforms, rising demand for biosimilars, adoption of smart sensors and internet of things (iot). Major trends in the forecast period include advances in robotics and automation technologies, advancements in single-use technologies, integration of artificial intelligence in bioprocessing, advances in process analytical technologies (pat), collaboration between biopharma and technology companies, emphasis on sustainability in biopharma automation.

The rising adoption of robots in pharmaceutical manufacturing is expected to drive the growth of automation in the biopharma industry market. Robots in this context refer to advanced automated systems and machines that carry out various tasks in the production and packaging of pharmaceutical products. They are utilized across multiple applications in pharmaceutical manufacturing, including secondary packaging, intralogistics, laboratory automation, pick and place, pharmacy process automation, and personalized medicine. This leads to greater productivity, enhanced precision, reduced contamination risks, and improved worker safety. For instance, in September 2024, the International Federation of Robotics, a Germany-based professional non-profit organization, reported that industrial robot installations in the manufacturing sector in Europe rose by 9%, reaching a record high of 92,393 units. Of these, 80% were installed within the European Union, totaling 73,534 units-a 2% increase from the previous year. Therefore, the growing adoption of robots in pharmaceutical manufacturing will drive the expansion of automation in the biopharma industry market.

The growth of automation in the biopharma industry market is further expected to be fueled by the increasing pace of drug development. The process of drug development involves the discovery and introduction of new pharmaceutical products to the market. As drug development intensifies, the automation of processes becomes essential within the biopharma industry. Automated systems play a crucial role in streamlining processes, expediting research, ensuring precision, and enhancing overall efficiency. For example, in 2022, the Center for Drug Evaluation and Research (CDER) granted approval to 37 new drugs, categorized as novel drugs, with 54% of them receiving approval in the same year. Hence, the surge in drug development activities acts as a catalyst for the growth of automation in the biopharma industry market.

A prominent trend in the automation in the biopharma industry market is the adoption of technological advancements by major companies. These companies are actively engaged in developing advanced product technologies to fortify their positions in the market. An illustration of this trend is observed in the actions of PerkinElmer Inc., a US-based company providing scientific solutions and technologies. In September 2022, PerkinElmer Inc. introduced the Cellaca PLX Image Cytometry System, an advanced automated cell analysis solution designed to simplify cell and gene therapy research and manufacturing. This platform enables researchers to assess critical quality attributes of cell samples, including identity, quantity, and quality, through an automated workflow. The integrated system encompasses image cytometer hardware, software, validated consumables, and trackable data reporting, streamlining calibration and training requirements.

Major companies in the automation in biopharma industry market are actively developing advanced technologies, including automated customer data platforms (CDP)To cater to a larger customer base, boost sales, and increase revenue. An automated CDP is a software solution designed to automatically collect, organize, and analyze customer data from diverse sources in a centralized manner. For instance, Tealium, a US-based provider of customer data orchestration tools, launched Tealium for Pharma in July 2022. This verticalized platform is meticulously crafted to fully automate and enhance the customer experience for Pharma audiences, addressing the challenges posed by dynamic privacy and security regulations in the industry. Tealium's data-first offering integrates and automates data seamlessly, resulting in an elevated customer experience while adhering to the highest standards of Health Insurance Portability and Accountability Act (HIPAA) compliance.

In April 2022, Bruker Corporation, a US-based company specializing in scientific instruments for molecular and materials research, acquired Optimal Industrial Automation Limited for an undisclosed amount. This acquisition positions Bruker as a key provider of software and solutions for small molecule, biologic, and new drug modalities in pharma companies. Optimal Industrial Automation Limited, based in the UK, offers pharmaceutical and biopharmaceutical automation solutions, including process analytical technology (PAT), manufacturing automation, quality assurance (QA) software, and systems integration.

Major companies operating in the automation in biopharma industry market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMerieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the automation in biopharma industry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The automation in biopharma industry market consists of revenues earned by entities by providing high-throughput screening, sample management, and cell culture automation used during the process. The market value includes the value of related goods sold by the service provider or included within the service offering. The automation in biopharma industry market also includes sales of automated dissolution testing systems, robotic sample storage and retrieval systems, and chromatography systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Automation In Biopharma Industry Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on automation in biopharma industry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for automation in biopharma industry ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The automation in biopharma industry market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technology: Automation Technology; Digitization Technology
• 2) By Component: Automation Hardware; Automation Software; Services Project Phase; Services Operation Phase
• 3) By Application: Clinical Phase; Drug Discovery Phase; Production Phase
• Subsegments:
• 1) By Automation Technology: Process Automation; Laboratory Automation; Robotics And Artificial Intelligence; Control Systems; Programmable Logic Controllers (PLCs)
• 2) By Digitization Technology: Data Analytics And Visualization; Electronic Lab Notebooks (ELN); Cloud Computing; Internet Of Things (IoT) In Pharma; Digital Twin Technology
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Danaher Corporation; ABB Ltd; Siemens Healthineers AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Automation In Biopharma Industry Market Characteristics

3. Automation In Biopharma Industry Market Trends And Strategies

4. Automation In Biopharma Industry Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Automation In Biopharma Industry Growth Analysis And Strategic Analysis Framework

• 5.1. Global Automation In Biopharma Industry PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Automation In Biopharma Industry Market Growth Rate Analysis
• 5.4. Global Automation In Biopharma Industry Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Automation In Biopharma Industry Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Automation In Biopharma Industry Total Addressable Market (TAM)

6. Automation In Biopharma Industry Market Segmentation

• 6.1. Global Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automation Technology
• Digitization Technology
• 6.2. Global Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automation Hardware
• Automation Software
• Services Project Phase
• Services Operation Phase
• 6.3. Global Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Phase
• Drug Discovery Phase
• Production Phase
• 6.4. Global Automation In Biopharma Industry Market, Sub-Segmentation Of Automation Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Process Automation
• Laboratory Automation
• Robotics And Artificial Intelligence
• Control Systems
• Programmable Logic Controllers (PLCs)
• 6.5. Global Automation In Biopharma Industry Market, Sub-Segmentation Of Digitization Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analytics And Visualization
• Electronic Lab Notebooks (ELN)
• Cloud Computing
• Internet Of Things (IoT) In Pharma
• Digital Twin Technology

7. Automation In Biopharma Industry Market Regional And Country Analysis

• 7.1. Global Automation In Biopharma Industry Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Automation In Biopharma Industry Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Automation In Biopharma Industry Market

• 8.1. Asia-Pacific Automation In Biopharma Industry Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Automation In Biopharma Industry Market

• 9.1. China Automation In Biopharma Industry Market Overview
• 9.2. China Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Automation In Biopharma Industry Market

• 10.1. India Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Automation In Biopharma Industry Market

• 11.1. Japan Automation In Biopharma Industry Market Overview
• 11.2. Japan Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Automation In Biopharma Industry Market

• 12.1. Australia Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Automation In Biopharma Industry Market

• 13.1. Indonesia Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Automation In Biopharma Industry Market

• 14.1. South Korea Automation In Biopharma Industry Market Overview
• 14.2. South Korea Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Automation In Biopharma Industry Market

• 15.1. Western Europe Automation In Biopharma Industry Market Overview
• 15.2. Western Europe Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Automation In Biopharma Industry Market

• 16.1. UK Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Automation In Biopharma Industry Market

• 17.1. Germany Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Automation In Biopharma Industry Market

• 18.1. France Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Automation In Biopharma Industry Market

• 19.1. Italy Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Automation In Biopharma Industry Market

• 20.1. Spain Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Automation In Biopharma Industry Market

• 21.1. Eastern Europe Automation In Biopharma Industry Market Overview
• 21.2. Eastern Europe Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Automation In Biopharma Industry Market

• 22.1. Russia Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Automation In Biopharma Industry Market

• 23.1. North America Automation In Biopharma Industry Market Overview
• 23.2. North America Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Automation In Biopharma Industry Market

• 24.1. USA Automation In Biopharma Industry Market Overview
• 24.2. USA Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Automation In Biopharma Industry Market

• 25.1. Canada Automation In Biopharma Industry Market Overview
• 25.2. Canada Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Automation In Biopharma Industry Market

• 26.1. South America Automation In Biopharma Industry Market Overview
• 26.2. South America Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Automation In Biopharma Industry Market

• 27.1. Brazil Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Automation In Biopharma Industry Market

• 28.1. Middle East Automation In Biopharma Industry Market Overview
• 28.2. Middle East Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Automation In Biopharma Industry Market

• 29.1. Africa Automation In Biopharma Industry Market Overview
• 29.2. Africa Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Automation In Biopharma Industry Market Competitive Landscape And Company Profiles

• 30.1. Automation In Biopharma Industry Market Competitive Landscape
• 30.2. Automation In Biopharma Industry Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. ABB Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Automation In Biopharma Industry Market Other Major And Innovative Companies

• 31.1. Emerson Electric Co.
• 31.2. Becton Dickinson and Company (BD)
• 31.3. Corning Incorporated
• 31.4. Rockwell Automation Inc.
• 31.5. Agilent Technologies Inc.
• 31.6. PerkinElmer Inc.
• 31.7. Sartorius AG
• 31.8. bioMerieux SA
• 31.9. Mettler-Toledo International Inc.
• 31.10. Beckman Coulter Inc.
• 31.11. Waters Corporation
• 31.12. Pall Corporation
• 31.13. Bruker Corporation
• 31.14. Qiagen N.V.
• 31.15. Eppendorf AG

32. Global Automation In Biopharma Industry Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Automation In Biopharma Industry Market

34. Recent Developments In The Automation In Biopharma Industry Market

35. Automation In Biopharma Industry Market High Potential Countries, Segments and Strategies

• 35.1 Automation In Biopharma Industry Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Automation In Biopharma Industry Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Automation In Biopharma Industry Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer